Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis

Timothy Craig, Berrylin J. Ferguson, John H. Krouse

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Sleep impairment is a significant problem for patients with inflammatory disorders of the upper respiratory tract, such as allergic rhinitis, rhinosinusitis, and nasal polyposis. Nasal congestion, one of the most common and bothersome symptoms of these conditions, is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment. This review examines sleep impairment associated with allergic rhinitis, rhinosinusitis, and nasal polyposis. It explores the adverse effects of disturbed sleep on patients' quality of life and how these inflammatory nasal conditions can be reduced by therapies that address the underlying problems affecting sleep. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion in inflammatory disorders of the upper respiratory tract. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Further research using measures of sleep as primary end points is warranted, based on the potential of these agents to improve sleep and quality of life in patients with allergic rhinitis, acute rhinosinusitis, and nasal polyposis. Such trials will help to identify the most effective therapies for sleep impairment in these 3 nasal conditions.

Original languageEnglish (US)
Pages (from-to)209-217
Number of pages9
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume29
Issue number3
DOIs
StatePublished - May 1 2008

Fingerprint

Nose
Sleep
Quality of Life
Respiratory System
Adrenal Cortex Hormones
Allergic Rhinitis
Sleep Apnea Syndromes
Fatigue
Therapeutics
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{5d6b492bf98841e89d8f2a8c41f7f120,
title = "Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis",
abstract = "Sleep impairment is a significant problem for patients with inflammatory disorders of the upper respiratory tract, such as allergic rhinitis, rhinosinusitis, and nasal polyposis. Nasal congestion, one of the most common and bothersome symptoms of these conditions, is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment. This review examines sleep impairment associated with allergic rhinitis, rhinosinusitis, and nasal polyposis. It explores the adverse effects of disturbed sleep on patients' quality of life and how these inflammatory nasal conditions can be reduced by therapies that address the underlying problems affecting sleep. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion in inflammatory disorders of the upper respiratory tract. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Further research using measures of sleep as primary end points is warranted, based on the potential of these agents to improve sleep and quality of life in patients with allergic rhinitis, acute rhinosinusitis, and nasal polyposis. Such trials will help to identify the most effective therapies for sleep impairment in these 3 nasal conditions.",
author = "Timothy Craig and Ferguson, {Berrylin J.} and Krouse, {John H.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1016/j.amjoto.2007.06.002",
language = "English (US)",
volume = "29",
pages = "209--217",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "3",

}

Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. / Craig, Timothy; Ferguson, Berrylin J.; Krouse, John H.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 29, No. 3, 01.05.2008, p. 209-217.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis

AU - Craig, Timothy

AU - Ferguson, Berrylin J.

AU - Krouse, John H.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Sleep impairment is a significant problem for patients with inflammatory disorders of the upper respiratory tract, such as allergic rhinitis, rhinosinusitis, and nasal polyposis. Nasal congestion, one of the most common and bothersome symptoms of these conditions, is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment. This review examines sleep impairment associated with allergic rhinitis, rhinosinusitis, and nasal polyposis. It explores the adverse effects of disturbed sleep on patients' quality of life and how these inflammatory nasal conditions can be reduced by therapies that address the underlying problems affecting sleep. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion in inflammatory disorders of the upper respiratory tract. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Further research using measures of sleep as primary end points is warranted, based on the potential of these agents to improve sleep and quality of life in patients with allergic rhinitis, acute rhinosinusitis, and nasal polyposis. Such trials will help to identify the most effective therapies for sleep impairment in these 3 nasal conditions.

AB - Sleep impairment is a significant problem for patients with inflammatory disorders of the upper respiratory tract, such as allergic rhinitis, rhinosinusitis, and nasal polyposis. Nasal congestion, one of the most common and bothersome symptoms of these conditions, is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment. This review examines sleep impairment associated with allergic rhinitis, rhinosinusitis, and nasal polyposis. It explores the adverse effects of disturbed sleep on patients' quality of life and how these inflammatory nasal conditions can be reduced by therapies that address the underlying problems affecting sleep. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion in inflammatory disorders of the upper respiratory tract. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Further research using measures of sleep as primary end points is warranted, based on the potential of these agents to improve sleep and quality of life in patients with allergic rhinitis, acute rhinosinusitis, and nasal polyposis. Such trials will help to identify the most effective therapies for sleep impairment in these 3 nasal conditions.

UR - http://www.scopus.com/inward/record.url?scp=42749091322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749091322&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2007.06.002

DO - 10.1016/j.amjoto.2007.06.002

M3 - Article

C2 - 18439959

AN - SCOPUS:42749091322

VL - 29

SP - 209

EP - 217

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 3

ER -